@TheNewsOwl

Sounds promising!

This could revolutionize the precision medicine field because the drug targeting will only affect and kill cancer cells and spare the normal cells,” said Deepak Nagrath, a U-M associate professor of biomedical engineering and senior author of the study published in Nature Metabolism. “Most cancer drugs affect normal tissues and cells. However, our strategy allows specific targeting of cancer cells.”

@TheNewsOwl I’ll gladly sign up to try this out. I mean, what do I have to lose??